CHARLOTTE C SUN to Aromatase Inhibitors
This is a "connection" page, showing publications CHARLOTTE C SUN has written about Aromatase Inhibitors.
Connection Strength
0.809
-
Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors. Gynecol Oncol. 2020 12; 159(3):601-603.
Score: 0.606
-
Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival. Gynecol Oncol. 2022 11; 167(2):139-145.
Score: 0.174
-
Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience. Gynecol Oncol. 2017 04; 145(1):37-40.
Score: 0.029